A new study from UCLA Health suggests that compressing six weeks of transcranial magnetic stimulation into a single intensive five-day protocol may offer comparable symptom relief for many patients ...
Soterix Medical Inc., the global leader in non-invasive stimulation and integrated brain monitoring technologies, announced today clearance from the U.S. Food & Drug Administration (FDA) for the SPRY ...
For the many patients with depression who haven't found relief through medication, transcranial magnetic stimulation (TMS) - ...
WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) announced it has appointed Joshua C. Brown, MD, PhD, as chief medical innovation officer to support the company’s development of treatments ...
Co-authored by Eugene Rubin, M.D., Ph.D., and Charles Zorumski, M.D. About one-third of patients with major depressive disorder do not respond adequately to medications and/or psychotherapy. If an ...
Exploring Family Perspectives and Ongoing Research into EEG-Guided rTMS Approaches WIMBERLEY, TX, UNITED STATES, January 15, 2026 /EINPresswire.com/ — Brain ...